NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE: PFE) today announced positive topline results from a Phase 3 study of etrasimod, an…
Browsing: Hot headlines in GI
The North American Society for Pediatric Gastroenterology, Hepatology & Nutrition Fellows Committee, working in close partnership with the NASPGHAN Technology…
Tailored or even generic telephone messages increased colonoscopy for people not up to date on their colorectal cancer (CRC) screening,…
The FDA granted priority review to futibatinib for treatment of certain patients with cholangiocarcinoma. The designation applies to use of…
Raleigh, N.C. – Mar. 29, 2022 – Curi Advisory, Curi’s business unit focused on delivering data-driven business solutions and consulting services…
More than 70% of patients with metastatic colorectal cancer bore financial hardships within the first year of diagnosis despite most…
Irritable bowel syndrome (IBS) had quite a moment in the sun last year when TikTok users turned it into a “hot…
Risk for early-onset colorectal cancer (EOCRC) was not associated with recent antibiotic treatment, according to a study published in Clinical and…
Gastroenterologists concerned over the management of anticoagulant and antiplatelet drugs during gastrointestinal (GI) procedures now have new guidance in the…
A next-generation ink for endoscopic tattooing of the colon diffuses less and is more “biocompatible” than existing inks, which could help identify…